相关实验视频
Updated: Jun 21, 2025

03:37
Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
4.5K
阿里皮普拉剂量与代谢不良影响的关联:从纵向研究的结果
Marianna Piras1, Iris Popovic1, Setareh Ranjbar2
1Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
Schizophrenia research
|July 10, 2024
概括
阿里皮普拉的剂量会影响体重和随时间的代谢变化. 较高的剂量可能最初会导致更多的体重增加,但较低的剂量会在五个月后导致更大的增加,这表明患者需要谨慎的剂量管理.
科学领域:
- 心理药理学 心理药理学
- 代谢医学是一种代谢医学.
- 临床精神病学 临床精神病学
背景情况:
- 阿里皮普拉治疗可能导致体重增加和代谢失调.
- 阿里皮普拉剂量与这些代谢变化之间的关系尚未完全理解.
研究的目的:
- 调查阿里皮普拉剂量与体重,血糖,脂质和血压的变化之间的关联.
- 为了确定特定的阿里皮普拉剂量是否与增加的代谢风险相关.
主要方法:
- 分析了422名患者的数据,这些患者接受了阿里皮普拉治疗3周至1年.
- 利用线性混合效应模型来检查剂量-反应关系与代谢结果.
主要成果:
- 阿里皮普拉剂量与治疗时间相互作用,影响体重变化动态.
- 在5个月内,LDL和HDL胆固醇水平呈现剂量依赖的增加.
- 增加阿里皮普拉剂量与一年内临床显著体重增加的可能性更高相关.
结论:
- 阿里皮普拉的剂量与体重变化有关,特别是在考虑治疗持续时间时.
- 在治疗的最初五个月内,代谢参数可能会恶化,因此建议使用最小有效剂量.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
119
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
119
Psychosis and Antipsychotic Drugs: Overview
229
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
229
Antipsychotic Drugs: Typical and Atypical Agents
175
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
175
Psychosis: Goals of Pharmacotherapy
119
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
119
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215

